Sapient Contributes to Groundbreaking Study on Human Liver Metabolism Published in Nature Metabolism

The paper details an innovative approach for assaying metabolic activities in intact human liver tissue.

Global 13C tracing and metabolic flux analysis of intact human liver tissue ex vivo

This paper, published in Nature Metabolism, details a study making significant strides in the understanding human liver metabolism.

Join us at Biomarkers Europe 2024

Sapient will be presenting on multi-omics approaches to accelerate biomarker discovery & validation. See where to meet us.

Differential, Disease Modifying, Tractable: Identifying Optimal Drug Targets with Discovery Proteomics and AI

Explore how discovery proteomics combined with AI-based target validation can be used to match therapies to optimal targets.

The Scientist eBook: Bringing the Power of Multiomics Biomarker Discovery into Focus

Deep dive into the latest advances for gathering, integrating, and leveraging multiomics data for biomarker discovery.

Metabolite Identification Fact Sheet

Our comprehensive Metabolite Standards Library enhances the speed, quality, and extent of metabolite identification.

Sapient Announces Expanded, Enhanced Metabolite Identification Capabilities as Significant Advancement in Its Discovery Metabolomics & Lipidomics Services

See how these capabilities enhance the speed, quality & extent of metabolite identification for accelerated insights.

The Next Frontier in CDx: Protein-Based Companion Diagnostics

How next-gen proteomics methods for protein biomarker discovery are opening exciting new avenues in CDx development.

Targeted Proteomics Fact Sheet

Using mass spectrometry to deliver quantitative measures for specific proteins in plasma, cells, and tissue.

A New Golden Age for Target ID: Accessing the Novel Druggable Space with Discovery Proteomics

Now available on demand! See the scientific innovations expanding the druggable space and enabling discovery of novel targets.